Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Radiation with Mitomycin C or Porfiromycin in Head and Neck Cancer
NCT00002507Phase 3Completed
- Sponsor
- Yale University
- Start
- Nov 1992
- Primary completion
- Oct 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of porfiromycin in head and neck squamous cell carcinoma (HNSCC) (2 arms), sponsored by Yale University. Primary endpoint: Local Relapse-Free Survival at 5 years. Started Nov 1992; status: completed.
02
Drugs
porfiromycin
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT00002507.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002507.